Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 285 Lymphoma 201 Lymphoma, Large B-Cell, Diffuse 167 Sarcoma 141 Precursor Cell Lymphoblastic Leukemia-Lymphoma 109 Hodgkin Disease 85 Lymphoma, Non-Hodgkin 78 Burkitt Lymphoma 67 Lymphoma, Follicular 61 Leukemia 58 Ovarian Neoplasms 50 Neoplasms 50 Triple Negative Breast Neoplasms 49 Lymphoma, Mantle-Cell 48 Multiple Myeloma 47 Neuroblastoma 44 Carcinoma, Hepatocellular 44 Neoplasm Metastasis 41 Lymphoma, B-Cell 33 Lymphoma, Large-Cell, Anaplastic 31 Lymphoma, T-Cell, Peripheral 27 Recurrence 26 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 25 Osteosarcoma 25 Liposarcoma 25 Leiomyosarcoma 25 Urinary Bladder Neoplasms 23 Lymphoma, Large-Cell, Immunoblastic 23 Liver Neoplasms 22 Endometrial Neoplasms 21

Interventions

Radiotherapy 1 Paclitaxel 1 Olanzapine 1 Megestrol Acetate 1 Doxorubicin 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Prosthesis Failure × Doxorubicin × Clear all

NCT01918124 2018-10-12

EC-0701

Fudan University

Phase 2 Completed

Prosthesis Failure

Data powered by HemOnc (CC BY 4.0) Colophon ⚡